H.R. 4626 · 118th Congress (2023–2025)
OTC Act of 2023
This bill requires the Food and Drug Administration (FDA) to issue guidance on the approval process for over-the-counter oral contraceptives so as to encourage drug manufacturers to submit applications for approval. The FDA must also evaluate (1) whether and to what extent consumers understand the labeling on oral contraceptives, and (2) whether the labeling could be improved.
Show official title
To encourage sponsors of oral contraceptive drugs to submit applications for the approval of such drugs as over-the-counter, and for other purposes.
Expired in House committee
Derived from the legislative history, not an official disposition.
Latest actionReferred to Health
This bill’s path
This is H.R. 4626’s recorded path, not a universal congressional workflow.
How bills become lawAll actionsIntroduced
Passed House
Passed Senate
Sent to President
Signed into law
Expired
- Sponsor
- Rep. Mariannette Miller-Meeks (R-IA-1)
- Cosponsors
10 cosponsors
9 original · 1 later
10 R
- Rep. Stephanie I. Bice (R-OK-5)· Original · Jul 13, 2023
- Rep. Lori Chavez-DeRemer (R-OR-5)· Original · Jul 13, 2023
- Rep. Marjorie Taylor Greene (R-GA-14)· Original · Jul 13, 2023
- Rep. Diana Harshbarger (R-TN-1)· Original · Jul 13, 2023
- Rep. Young Kim (R-CA-40)· Original · Jul 13, 2023
- Rep. Jennifer A. Kiggans (R-VA-2)· Original · Jul 13, 2023
- Rep. Nancy Mace (R-SC-1)· Original · Jul 13, 2023
- Rep. Nicole Malliotakis (R-NY-11)· Original · Jul 13, 2023
- Rep. Maria Elvira Salazar (R-FL-27)· Original · Jul 13, 2023
- Rep. Ashley Hinson (R-IA-2)· Later · Sep 14, 2023
- Policy area
- Health
- Subjects
- Drug safety, medical device, and laboratory regulation
- Family planning and birth control
- Government information and archives
- Government studies and investigations
- Prescription drugs
- Women's health
On this page
Timeline
i
In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.
Introduced in House
Document: Introduced in House
Sources
- Congress.gov actionIntro-H
- Library of Congress
- Latest
▸ 2 committee actions · Jul 13, 2023 – Jul 14, 2023
Referred to committee
Referred to the House Committee on Energy and Commerce.
Sources
- Congress.gov action
- House floor actions
Referred to Health
Referred to the Subcommittee on Health.
Sources
- Congress.gov action
- House committee actions
Expired
Introduced → Referred to House Health → No further action before the 118th Congress ended.
Committees
Text & titles
i
Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.
| Version | Date | Links |
|---|---|---|
| Introduced in House |
Titles (3)
OTC Act of 2023
Display title, Short title · Introduced in House
Orally Taken Contraception Act of 2023
Short title · Introduced in House
To encourage sponsors of oral contraceptive drugs to submit applications for the approval of such drugs as over-the-counter, and for other purposes.
Official title · Introduced in House